Finvest
RLX Consumer Staples · China ADR · E-vapor · International growth · Thesis updated July 20, 2026

RLX's growth now depends on regulated vapes

01 Running thesis

A global vape bet

RLX used to look mostly like a China e-vapor company. That has changed. After a non-compete ended, the company pushed hard overseas. Management said international sales were 76.5% of revenue in Q4 2025 and still above 70% in Q1 2026.

The bull case is that RLX is becoming a scale player in regulated nicotine alternatives. Q1 2026 revenue rose 96.2% year over year. Nexus, its new smart manufacturing hub, should help it move faster, protect its designs, and keep product quality tight.

Regulation is the swing factor. The U.K. Tobacco and Vapes Act became law in April 2026. It bans cigarette sales to future generations but keeps the adult e-vapor age at 18. RLX says this can make compliant e-vapor one of the few legal nicotine paths for future adult users.

The bear case is real. China is still hurt by illegal products. Europe and APAC can change rules quickly. Q1 also got help from temporary channel orders before China's export tax rebate ended, so investors should not treat that whole growth rate as clean demand.

May 2026Q1 2026 revenue rose 96.2% year over year, Nexus became fully operational, and management framed the U.K. Tobacco and Vapes Act as a major tailwind. The note is tempered by a temporary order pull-forward before China's export tax rebate ended.
Mar 2026Q4 2025 showed the international pivot had real scale, with international sales at 76.5% of revenue. Management also highlighted an AI-aided supply chain tied to local retail networks.
Nov 2025Q3 2025 strengthened the overseas thesis, with 70% to 80% of revenue coming from international markets. RLX also moved its U.K. business toward a multi-brand retail distribution model and began scaling modern oral products.
Aug 2025Q2 2025 added the European acquisition to reported results and expanded RLX's role into retail and distribution. China improved somewhat from enforcement, but illegal products still dominated the domestic market.
May 2025Q1 2025 showed that disposable bans in the U.K. and New Zealand were forcing a product shift toward Big Puff devices. That helped volume but hurt average price per liquid volume, making 2025 a transition year.
Apr 2025The 2024 annual report confirmed the international plan, including expansion into three APAC markets in 2024 and a March 2025 investment in Europe. The China weakness remained the key offset.
Nov 2024The initial view centered on RLX's pivot outside China after a non-compete ended. International revenue had moved above half of revenue, while illegal China products were still estimated at 80% to 90% of the domestic market.
02 Business model

From brand seller to channel owner

RLX designs, develops, makes, and distributes e-vapor products. It sells devices and pods across price levels, then uses brand, retail partners, and local rules to win adult users market by market.

The model is getting more integrated. Nexus brings R&D, manufacturing, and commercial work into one site. That can lower response time when a country changes product rules, and it can help keep product ideas inside the company.

Europe changed the shape of the company. After a 2025 investment in a compliant European e-vapor company, RLX now acts there as a retailer, distribution partner, and brand operator. That means RLX can sell its own products, but also use acquired channels to carry other brands.

This model can break if rules turn against the category, if local warehouses and retail links do not add enough sales, or if cheaper illegal products keep taking share. The business needs both compliance and speed.

03 Product portfolio

Pods, big puffs, and options

Cash cow

Cartridge systems

Qingyu, Phantom, and Phantom Plus cover low to high price tiers. These are the core refill or cartridge products that built the brand.

Growth engine

Large-volume compliant disposables

Daqen and Feiyue target users moving away from small-puff disposables as bans take effect. The shift can lift volume, but lower price per liquid volume can pressure revenue.

Growth engine

International tailored devices

RLX Prime and RLX Bin are built for overseas markets with local preferences and rules in mind. This is central to the Asia and Europe plan.

Option

Modern oral products

RLX is scaling ultra-thin, fast absorbent modern oral products. This gives it a path into smokeless nicotine beyond e-vapor.

Option

Heated tobacco

Management says RLX has the technical ability to enter heated tobacco, but no immediate launch plan. The company sees better near-term returns in e-vapor.

04 Business segments

Mostly outside China now

International76%growing fast
Mainland China24%modest

The exact mix shown uses Q4 2025, when management said international sales were 76.5% of revenue. In Q1 2026, management said international sales stayed above 70%, but did not give an exact split.

05 Risk factors

What could go wrong

Illegal China products keep winning

High impact · High odds

RLX has said illegal e-vapor products made up an estimated 80% to 90% of China's domestic market. If that stays true, the China business can remain smaller and less profitable than the brand would suggest.

We watchManagement comments on illegal product share in China and any official enforcement updates.

Europe changes the rules again

High impact · Medium odds

The U.K. law is favorable for e-vapor versus cigarettes, but Europe is still a patchwork of rules. A flavor ban, product standard change, or harsh tax in a key market could slow RLX's fastest growth area.

We watchU.K. vaping product duty in October 2026, HMRC licensing rules, and new EU or country-level vape rules.

Q1 growth proves partly temporary

Medium impact · Medium odds

Q1 2026 revenue rose 96.2% year over year, but management said some orders were pulled forward before China's export tax rebate ended in April 2026. If later quarters slow sharply, the market may cut its view of RLX's true growth rate.

We watchSequential revenue growth, inventory turnover days, and whether Q2 and Q3 demand holds after the rebate change.

Big Puff pricing hurts sales dollars

Medium impact · Medium odds

Users are shifting from small-puff disposables to larger compliant devices in some markets. That can raise e-liquid volume but lower average selling price per liquid volume, which can hold back reported revenue.

We watchGross margin, average selling price comments, and mix between Big Puff devices and cartridge systems.

European integration falls short

Medium impact · Medium odds

RLX is counting on local warehouses, acquired retail channels, and multi-brand distribution to build scale in Europe. If those assets do not add enough sell-through, the acquisition may lift reported revenue but not long-term value.

We watchEuropean channel expansion, warehouse utilization, and management comments on downstream retail resources.
06 Quick answers

In one breath

What does RLX Technology do?

RLX makes e-vapor products, including cartridge systems, larger compliant disposables, and overseas devices. It is also building modern oral nicotine products.

Why is RLX focused on international markets?

China has been hurt by illegal products, so RLX shifted overseas after a non-compete ended. International sales were 76.5% of Q4 2025 revenue and stayed above 70% in Q1 2026.

Is U.K. regulation good or bad for RLX?

For now, it looks more helpful than harmful. The U.K. law bans future cigarette sales by birth year but keeps adult e-vapor sales legal, while new taxes and licensing may push out non-compliant sellers.

Will RLX launch heated tobacco products?

Management says it has the needed technical ability, but no immediate launch plan. RLX is putting its near-term focus on e-vapor and modern oral products.